NCT05079256Completed
Laser Induced Changes to Innervation and Vascularisation of Psoriatic Skin
A Preliminary Study on the Effect of Photothermal Laser Therapy on the Vascularization and Innervation of Psoriatic Lesions
Source: ClinicalTrials.gov · Last updated 22 Jan 2025
Brief summary (registry, in English)
The researchers investigate the effect of a treatment with selective photothermolysis using a 595 nm pulsed dye laser on the blood vessel density and the nerve fibre density of a psoriatic lesion. By comparing tissue samples collected before and after two treatments, the researchers determine the relative effect of laser therapy on the (hyper)innervation of psoriatic skin.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 22 (actual)
- First submitted
- 20 Sept 2021
- Start date
- 9 Dec 2022
- Primary completion date
- 12 Oct 2024
- Lead sponsor
- Nick van der Beek
- Diseases
- Psoriasis
- NCT number
- NCT05079256
What you commit to
- Study type: Interventional
- Participants enrolled: 22
- From 9 Dec 2022 to the primary completion date, 12 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The participant uses other treatments (than laser therapy) during the study or two weeks before the start of the study that are known to affect psoriasis
Other illness
- The participant suffers from any known neurological, vascular, or immunological condition other than psoriasis.
- The participant is allergic to lidocaine
Other
- A potential subject who meets any of the following criteria will be excluded from participation in this study if:
Who the study is looking for
- 18 - 69 years of age
- Psoriasis vulgaris
- Skin type I - III
- Minimal surface of lesion of 3 cm2
- Contralateral psoriasis vulgaris lesions located on chest, back, or upper legs
Age in the registry: 18 years to 69 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ZBC Multicare Coordinator of this site? Confirm its status | Hilversum | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.